Foghorn Therapeutics Completes Kendall Square Headquarters

Published 3-15-2021
  • Foghorn Therapeutics - Kendall Square Headquarters
  • Foghorn Therapeutics - Kendall Square Headquarters
  • Foghorn Therapeutics - Kendall Square Headquarters
  • Foghorn Therapeutics - Kendall Square Headquarters
  • Foghorn Therapeutics - Kendall Square Headquarters
  • Foghorn Therapeutics - Kendall Square Headquarters
  • Foghorn Therapeutics - Kendall Square Headquarters
  • Foghorn Therapeutics - Kendall Square Headquarters

    Courtesy of TRIA.

  • Foghorn Therapeutics - Kendall Square Headquarters

    Courtesy of TRIA.

  • Foghorn Therapeutics - Kendall Square Headquarters

    Courtesy of TRIA.

  • Foghorn Therapeutics - Kendall Square Headquarters

    Courtesy of TRIA.

  • Foghorn Therapeutics - Kendall Square Headquarters

    Courtesy of TRIA.

  • Foghorn Therapeutics - Kendall Square Headquarters

    Courtesy of TRIA.

  • Foghorn Therapeutics - Kendall Square Headquarters

    Courtesy of TRIA.

Foghorn Therapeutics completed construction in March of 2021 on its 60,000-sf headquarters in Kendall Square in Cambridge, Mass. Spanning three renovated floors in the 500 Technology Square building, the collaborative facility provides leading-edge environments to support crucial biomedical research including chemistry and biology labs, open offices, conference rooms, and huddle rooms. TRIA designed the fast-track project, which was built by Wise Construction with R.W. Sullivan as engineering consultant and Code Red Consultants as code consultant. Building Information Modeling (BIM) was employed in the delivery of Foghorn’s headquarters, which is owned by Alexandrea Real Estate Equities and managed by CBRE. Ground was broken on the project in January of 2020.

Related Organizations
TRIA
Architect
Wise Construction
Construction Manager
R.W. Sullivan, Inc.
Engineering Consultant
Code Red Consultants, LLC
Code Consultant
CBRE, Inc.
Leasing Agent
New England Lab
Laboratory Furniture Distributor